About Shalini Sharp
Form D filings for Mahzi Therapeutics from 2021 to 2024 list Shalini Sharp as director.
Shalini Sharp first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Shalini Sharp in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Shalini Sharp works with at each company, as listed on that company's latest Form D.
Mahzi Therapeutics Inc. · Form D/A, Jul 8, 2024
CS
Camille Samuels
Director
SF
Stephen Farr
Director
MS
Marten Steen
Director
YW
Yael Weiss
Chief Executive Officer and director